EXCLUSIVE LICENSE AGREEMENT between EAGLE PHARMACEUTICALS, INC. and CEPHALON, INC. dated February 13, 2015Exclusive License Agreement • February 12th, 2016 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 12th, 2016 Company Industry JurisdictionThis Exclusive License Agreement (this “Agreement”) is entered into as of February 13, 2015 (the “Effective Date”) by and between Eagle Pharmaceuticals, Inc., a Delaware corporation (“Eagle”) and Cephalon, Inc., a Delaware corporation (“Cephalon”). Eagle and Cephalon are sometimes referred to herein, individually, as a “Party” or, collectively, as “Parties.”
EXCLUSIVE LICENSE AGREEMENT between EAGLE PHARMACEUTICALS, INC. and CEPHALON, INC. dated February 13, 2015Exclusive License Agreement • May 15th, 2015 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2015 Company Industry JurisdictionThis Exclusive License Agreement (this “Agreement”) is entered into as of February 13, 2015 (the “Effective Date”) by and between Eagle Pharmaceuticals, Inc., a Delaware corporation (“Eagle”) and Cephalon, Inc., a Delaware corporation (“Cephalon”). Eagle and Cephalon are sometimes referred to herein, individually, as a “Party” or, collectively, as “Parties.”